| __timestamp | Dr. Reddy's Laboratories Limited | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 675200000 |
| Thursday, January 1, 2015 | 42585000000 | 771800000 |
| Friday, January 1, 2016 | 45702000000 | 1205500000 |
| Sunday, January 1, 2017 | 46372000000 | 1146500000 |
| Monday, January 1, 2018 | 46910000000 | 1125800000 |
| Tuesday, January 1, 2019 | 48890000000 | 1166100000 |
| Wednesday, January 1, 2020 | 50129000000 | 1175500000 |
| Friday, January 1, 2021 | 54559000000 | 1111400000 |
| Saturday, January 1, 2022 | 62081000000 | 1210100000 |
| Sunday, January 1, 2023 | 105931000000 | 1274600000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Dr. Reddy's Laboratories Limited and Perrigo Company plc from 2014 to 2023. Over this period, Dr. Reddy's Laboratories has shown a remarkable increase in SG&A expenses, peaking at approximately 106 billion in 2023, a staggering 173% rise from 2014. In contrast, Perrigo's SG&A expenses have remained relatively stable, with a modest increase of around 89% over the same period, reaching 1.27 billion in 2023. This disparity highlights Dr. Reddy's aggressive expansion and operational strategies compared to Perrigo's more conservative approach. Notably, data for 2024 is incomplete, indicating potential shifts in future trends. Such insights are invaluable for investors and industry analysts alike, offering a glimpse into the strategic priorities of these pharmaceutical giants.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?